New data in cannabis use disorder show investigational drug PP-01 cuts irritability 42% in trials.
Ginger Constantine, MD
Advertisement
Articles by Ginger Constantine, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Phase 2 Trial Initiated for Briumvi for Treatment-Resistant Schizophrenia
2
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
3
The Biggest Challenge in Treating Alzheimer Disease: A Conversation With Oleg Tcheremissine, MD
4
Presenting Our July 2026 Theme: Substance Use
5